Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 11/20 | 0.58 |
| ▸ | ITGAV | P06756 | 9/20 | 0.58 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.58 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.58 |
| ▸ | ITGB5 | P18084 | 5/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | MC4R | P32245 | 8/20 | 0.51 |
| ▸ | MC5R | P33032 | 8/20 | 0.51 |
| ▸ | MC3R | P41968 | 8/20 | 0.51 |
| ▸ | MC1R | Q01726 | 8/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24253222 | 1.00 | ITGB3 (0.58) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL11417675 | 0.94 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL24253294 | 0.93 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL23823921 | 0.93 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL20822613 | 0.93 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL22970200 | 0.93 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL21577745 | 0.93 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL15397366 | 0.92 | ITGB3 (0.60) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL10138534 | 0.92 | ITGB3 (0.60) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL22970321 | 0.91 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | disclosed |